The importance of oxygen role during aging process of wine has been long known. Many articles evaluating oxygen inlet for different wine stoppers have been published. However, none of these have studied the impact of the natural cork stoppers production process over oxygen inlet. At the moment, a standardized methodology widely accepted for measuring the oxygen transfer rate (OTR) and/or oxygen permeability of the stopper does not exist. Thus, this article is focused on the aging process (the final phase of the winemaking) and aims to test how some production process of natural cork stoppers impact on the stoppers permeability using chemiluminescence methodology and how also this affects wine ageing. In this study it has been seen that some of its processes such as the application of a surface treatment modify the permeability of the stopper. Surface plays an important role in the corks stoppers production and allows an easier insertion and extraction of the stopper into the bottle, avoiding leaks and homogenizing the stoppers. It was shown that the cork stoppers sample with surface treatment 1 had three times higher oxygen transfer rate than the cork stoppers sample with surface treatment 2 after one year of evolution. The two groups of stoppers had the same in terms of dimensions, density, visual class, batch and manufacture, the only difference between them was the surface treatment used. A red wine was corked with these two types of cork stoppers and its evolution was monitored up to 30 months of ageing. Differences were observed in the evolution of the wines both in certain oenological parameters such as the free SO2, the colour and the evolution of the polyphenols as well as at the sensory level. The wine corked with the stoppers of treatment 1 presented a faster evolution and a higher valuation in the sensory tastes of months 12th, while from the 18th month it presented an over evolution, and the score was below that of the wine with the corks of treatment 2.The data collected in this study shows that the differences observed with the chemiluminescence methodology of cork permeability test at a laboratory level are transferred to wine at the cellar. Therefore, it paves the way to standardize chemiluminescence as a methodology for permeability testing of cork stoppers. This opens a new field for the regulation of the permeability of natural cork stoppers by type of surface treatment applied.

ozone-based chemiluminescence detection (CLD) has been widely applied for determining nitric oxide (NO) and its derived species in many different fields, such as environmental monitoring and biomedical research. In humans CLD was applied to determine exhaled NO and NO metabolites in biological samples. The main advantages of CLD are high sensitivity and selectivity for quantitative analysis in a wide dynamic range. Combining CLD with analytical separation techniques like gas or liquid chromatography allows the analytes to be quantified with less disturbance from matrix components or impurities. Sampling techniques like microdialysis and flow injection analysis may be coupled to CLD with the possibility of real-time monitoring of NO. However, details and precautions in experimental practice need to be addressed and clarified to avoid wrongly estimating. Therefore, using CLD as a detection tool requires a deep understanding of sample preparation procedure and chemical reactions used for liberating NO from its derived species. In this review, we discuss the advantages and pitfalls of CLD for determining NO species, the different applications and combinations with other analytical techniques, and provide general practical notes for sample preparation. These guidelines should help other researchers understand CLD data and select the best procedure for detecting NO species.

Aim: This analytical cross-sectional study aimed to examine whether there is a correlation between tumor differentiation and certain biomarkers in patients with hepatocellular carcinoma (HCC). Methods: Poorly differentiated (n=443), moderately differentiated (n=379), and well-differentiated (n=272) tumors were separated from the research population, along with a control group (n=364). Biopsies were used to establish the presence of HCC, and biomarker levels were analyzed using chemiluminescence immunoassays in both infected and uninfected individuals. Results: The correlation between age and tumor size was shown to be statistically significant (p0.05) across all subgroups using both descriptive and inferential statistics. Patients with hepatitis C virus and non-A, non-B hepatitis had more advanced tumors than those with other types of poorly differentiated liver cancer. Similarly, individuals with HBsAg and moderate differentiation had bigger tumors, although there was no correlation between hepatitis C and non-A, non-B. Patients with HBsAg or hepatitis C had bigger tumors in the well-differentiated group, albeit the hepatitis C connection was not statistically significant. In addition, the study stressed that tumor size increases with age and that farmers were the most commonly diagnosed profession category. Conclusions: It is clear that early detection in infected populations is crucial for improving HCC outcomes and that chemiluminescence immunoassay has the potential to be a helpful platform for biomarker research. However, the study is limited by its small sample size and its emphasis on only three tumor markers, indicating that more biomarker research is required to improve the accuracy of HCC diagnosis and prognosis.

Cardiac vascular diseases, especially acute myocardial infarction (AMI), are one of the leading causes of death worldwide. Therefore cardio-specific biomarkers such as cardiac Troponin I (cTnI) play an essential role in diagnostics. In order to enable rapid and accurate measurement of cTnI with the potential of online measurements, a proof of concept of a chemiluminescence-based biosensor is presented. A flow cell was designed and combined with a sensitive CMOS camera allowing an optical readout. In addition, a microfluidic setup was established, and cTnI was determined selectively. The biomarker cTnI was expressed in E. coli, and its characterization and correct folding were investigated by different analytical methods. This recombinant cTnI was used for enzyme-linked immunosorbent assays (ELISA), calibrated against commercially available recombinant cTnI, and applied for the biosensor measurements. Based on chemiluminescence detection, the biosensor was successfully tested, and the cTnI biomarker could be reproducibly determined in buffer, spiked blood serum, and plasma.